MD­MA psy­chother­a­py tri­al put on pause af­ter Health Cana­da in­spec­tion

A Cana­di­an clin­i­cal tri­al in­ves­ti­gat­ing MD­MA-as­sist­ed psy­chother­a­py has been put on hold by Health Cana­da over some stark breaks in clin­i­cal good prac­tices.

Ac­cord­ing to a re­port from the Cana­di­an Broad­cast­ing Cor­po­ra­tion, the Phase II tri­al spon­sored by a men­tal health char­i­ty, the Rem­e­dy In­sti­tute, was is­sued a non-com­pli­ant rat­ing on June 22 by Health Cana­da.

Health Cana­da’s found a mul­ti­tude of con­cerns with the tri­al in­clud­ing the in­sti­tute not fol­low­ing the tri­al’s over­all pro­to­col.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER